Search research articles
Contact Us
Filters
Showing results (61-70 of 386) with videos related to
Page
of 39
Sort By:
Hepatology (Baltimore, Md.)
|
April 8, 2021
Letter to the Editor: Is Balloon-Occluded Retrograde Transvenous Obliteration Superior to Endoscopic Cyanoacrylate in Gastric Varices?
Krishna Kumar Chinnadurai, Arka De, Ajay Duseja, et al.
Gut
|
April 17, 2026
Offspring MASLD risk and the shared familial metabolic milieu: beyond intrauterine explanation
Jithin J Chandran, Naveen Bhagat, Arka De, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 25, 2010
Noncirrhotic portal fibrosis and abdominal varices
Sunil Taneja, Naveen Kalra, Ajay Duseja, et al.
Calcified Tissue International
|
August 9, 2025
Effect of Oral Semaglutide on Volumetric BMD and Bone Microarchitecture in Overweight/Obese Individuals with Type 2 Diabetes
Liza Das, Sanjay Kumar Bhadada, Durairaj Arjunan, et al.
Journal of Hepatology
|
September 16, 2021
NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver
Arka De, Nishat Ahmad, Manu Mehta, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 2, 2006
Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center
Nitin Saini, Ashish Bhagat, Sanjeev Sharma, et al.
Journal of Clinical and Experimental Hepatology
|
April 14, 2025
Unearthing <i>TULP3</i> Mutation as a Rare Cause of Cryptogenic Cirrhosis: A Case Report and Review of the Literature
Arpit Shastri, S Balaraja, Arka De, et al.
Journal of Clinical and Experimental Hepatology
|
December 23, 2016
Enucleation Sign: A Computed Tomographic Appearance of Ruptured Hepatocellular Carcinoma
Manphool Singhal, Upasna Sinha, Naveen Kalra, et al.
Journal of Hepatology
|
August 9, 2023
Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD
Arka De, Naveen Bhagat, Manu Mehta, et al.
Journal of Clinical and Experimental Hepatology
|
November 7, 2022
Lysosomal Acid Lipase Activity in Non-alcoholic Fatty Liver Disease as a Novel Diagnostic and Therapeutic Target: A Systematic Literature Review of Current Evidence and Future Directions
Aamir Bashir, Ajay Duseja, Ashish Verma, et al.
Page
of 39
Search research articles
Search
Showing results (61-70 of 386) with videos related to
Sort By:
Page
of 39
Hepatology (Baltimore, Md.)
|
April 8, 2021
Letter to the Editor: Is Balloon-Occluded Retrograde Transvenous Obliteration Superior to Endoscopic Cyanoacrylate in Gastric Varices?
Krishna Kumar Chinnadurai, Arka De, Ajay Duseja, et al.
Gut
|
April 17, 2026
Offspring MASLD risk and the shared familial metabolic milieu: beyond intrauterine explanation
Jithin J Chandran, Naveen Bhagat, Arka De, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 25, 2010
Noncirrhotic portal fibrosis and abdominal varices
Sunil Taneja, Naveen Kalra, Ajay Duseja, et al.
Calcified Tissue International
|
August 9, 2025
Effect of Oral Semaglutide on Volumetric BMD and Bone Microarchitecture in Overweight/Obese Individuals with Type 2 Diabetes
Liza Das, Sanjay Kumar Bhadada, Durairaj Arjunan, et al.
Journal of Hepatology
|
September 16, 2021
NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver
Arka De, Nishat Ahmad, Manu Mehta, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 2, 2006
Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center
Nitin Saini, Ashish Bhagat, Sanjeev Sharma, et al.
Journal of Clinical and Experimental Hepatology
|
April 14, 2025
Unearthing <i>TULP3</i> Mutation as a Rare Cause of Cryptogenic Cirrhosis: A Case Report and Review of the Literature
Arpit Shastri, S Balaraja, Arka De, et al.
Journal of Clinical and Experimental Hepatology
|
December 23, 2016
Enucleation Sign: A Computed Tomographic Appearance of Ruptured Hepatocellular Carcinoma
Manphool Singhal, Upasna Sinha, Naveen Kalra, et al.
Journal of Hepatology
|
August 9, 2023
Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD
Arka De, Naveen Bhagat, Manu Mehta, et al.
Journal of Clinical and Experimental Hepatology
|
November 7, 2022
Lysosomal Acid Lipase Activity in Non-alcoholic Fatty Liver Disease as a Novel Diagnostic and Therapeutic Target: A Systematic Literature Review of Current Evidence and Future Directions
Aamir Bashir, Ajay Duseja, Ashish Verma, et al.
Page
of 39